Runway Growth Finance Corp. 7.25% Notes due 2031
NASDAQ:RWAYI · NASDAQ Global Market
+$0.01 today
Vol 0.00M · Avg 0.01M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
No return metrics data available.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Colleen Corwell | Chief Compliance Officer | — | — | 57 | — | — |
Avisha Khubani | Chief Credit Officer | — | — | — | — | — |
John David Tamas | Managing Director of Healthcare & Life Sciences Investing | — | — | — | — | — |
David R. Spreng | Founder, President, CEO, Chief Investment Officer & Director | — | — | 63 | — | — |
Ryan McCarthy | Managing Director | — | — | — | — | — |
Ted Cavan | Managing Director of Technology | — | — | — | — | — |
Thomas Raterman | CFO, COO, Secretary & Treasurer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
Competitors
Peer companies in the same sector
No competitor data available.
Who manages RWAYI?
Runway Growth Finance Corp. 7.25% Notes due 2031 (RWAYI) lists 7 active executives. The top listed executive is Colleen Corwell, Chief Compliance Officer.
Explore More
Continue the stock analysis
Jump to another research area for this company.